Hexalin Pharmaceuticals Private Limited
About Hexalin Pharmaceuticals Private Limited
Data last updated:
Hexalin Pharmaceuticals Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24290CT2020PTC009952.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Animesh Nandan Sahay and Archana Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hdd – II 65 Phase 2 Kabir Nagar, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.22 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹52,304 (net margin 2.4%) and EBITDA of ₹1.33 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
The company is associated with 1 brand: Hexalin Pharmaceuticals.
Company details
Contact details
Hexalin Pharmaceuticals Private Limited's registered office is in Raipur, Chhattisgarh.
- Registered AddressHdd – II 65 Phase 2 Kabir Nagar, Raipur, Chhattisgarh, India – 492001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Hexalin Pharmaceuticals operates one associated brand: HEXALIN PHARMACEUTICALS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products manufacturing and supply in India. | hexalinpharmaceuticals.com |
Business activity
The main business activity of Hexalin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hexalin Pharmaceuticals Private Limited, buy the company report.
Financials of Hexalin Pharmaceuticals Private Limited
FY 2025 filings availableHexalin Pharmaceuticals Private Limited reported revenue of ₹22.22 Lakh (up 49% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over three years, including 49% growth in the latest year. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52,304 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hexalin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hexalin Pharmaceuticals Private Limited
Hexalin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Animesh Nandan Sahay | Director | 05 Feb 2020 | 6 Years 8 Months | Current |
| Archana Sahay | Director | 05 Feb 2020 | 6 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Hexalin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hexalin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hexalin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hexalin Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Animesh Nandan Sahay was appointed as Director on 05 Feb 2020.
Frequently asked questions
Hexalin Pharmaceuticals is an active private limited company based in Raipur, Chhattisgarh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 February 2020 (6+ years old) and is registered under CIN U24290CT2020PTC009952.
Hexalin Pharmaceuticals has 2 current directors:
- Animesh Nandan Sahay - Director
- Archana Sahay - Director
The latest financial statements of Hexalin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Hexalin Pharmaceuticals is U24290CT2020PTC009952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hexalin Pharmaceuticals was incorporated on 05 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
Animesh Nandan Sahay was appointed as Director on 05 Feb 2020. Archana Sahay was appointed as Director on 05 Feb 2020.
The registered office of Hexalin Pharmaceuticals is at Hdd – II 65 Phase 2 Kabir Nagar, Raipur, Chhattisgarh, India – 492001.
Hexalin Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Hexalin Pharmaceuticals has 1 associated brand: Hexalin Pharmaceuticals.
Hexalin Pharmaceuticals can be reached at its registered office: Hdd – II 65 Phase 2 Kabir Nagar, Raipur, Chhattisgarh, India – 492001.